Affirm Journal of Drug Design

Affirm Journal of Drug Design is an international and peer-reviewed journal with an intercontinental advisory board. The journal documents the professional’s interest in any areas that connect to drug design. The focus of the journal is on theories and practice in structural or molecular biological studies, drug target identification and validation, computer-aided drug design, and new methods and applications in drug design. The editorial board of the Affirm Journal of Drug Design invites authors to submit original papers, case studies and review papers to the journal. At Affirm Journal of Drug Design, we expect the authors to abide Principles of Transparency and Best Practice in Scholarly Publishing suggested by The Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and Scopus.

Scope and Focus

Drug Target Identification and Validation
Biochemical Analyses of Drug Targets
New Methods and Applications in Drug Design
Structural or Molecular Biological Studies
Anti-Cancer Drug Design
Computer-Aided Drug Design
Design of Artificial Blood Substitutes

Editor in chief

Dr. Loghman

Abstracting and Indexing

Google Scholar